Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Valerius

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Der Internist|February 7, 1998
[Antibodies as specific tumor therapy agents. Wishful thinking or reality?]M Gramatzki, T Valerius
Krankenpflege (Frankfurt Am Main, Germany)|April 1, 1974
[Anesthesia and intensive care. IV. Diagnostic and therapeutic nerve blocks]T Valerius, B Tiemann
Krankenpflege (Frankfurt Am Main, Germany)|August 1, 1974
[Anesthesia and intensive care. VIII. Resuscitation in the hospital]T Valerius, B Tiemann
Clinical and Experimental Immunology|August 22, 2003
Engineered CD3 antibodies for immunosuppressionL Renders, T Valerius
Critical Reviews in Oncology/Hematology|June 22, 2001
IgA antibodies for cancer therapyM Dechant, T Valerius
Krankenpflege (Frankfurt Am Main, Germany)|November 1, 1973
[Anesthesia and intensive therapy]M Halmágyi, T Valerius
Schwestern Revue|May 15, 1975
[Intensive care]T Valerius, L Müller
Krankenpflege (Frankfurt Am Main, Germany)|June 1, 1974
[Anesthesia and intensive care. VII. Cardiopulmonary resuscitation without equipment]T Valerius, B Tiemann
Krankenpflege (Frankfurt Am Main, Germany)|September 1, 1974
[Anesthesia and intensive care. IX. Teaching aids and teaching methods in resuscitation]T Valerius, B Tiemann
Critical Reviews in Oncology/Hematology|March 20, 2001
Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapyH H van Ojik, T Valerius
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Der Internist|February 7, 1998
[Antibodies as specific tumor therapy agents. Wishful thinking or reality?]M Gramatzki, T Valerius
Krankenpflege (Frankfurt Am Main, Germany)|April 1, 1974
[Anesthesia and intensive care. IV. Diagnostic and therapeutic nerve blocks]T Valerius, B Tiemann
Krankenpflege (Frankfurt Am Main, Germany)|August 1, 1974
[Anesthesia and intensive care. VIII. Resuscitation in the hospital]T Valerius, B Tiemann
Clinical and Experimental Immunology|August 22, 2003
Engineered CD3 antibodies for immunosuppressionL Renders, T Valerius
Critical Reviews in Oncology/Hematology|June 22, 2001
IgA antibodies for cancer therapyM Dechant, T Valerius
Krankenpflege (Frankfurt Am Main, Germany)|November 1, 1973
[Anesthesia and intensive therapy]M Halmágyi, T Valerius
Schwestern Revue|May 15, 1975
[Intensive care]T Valerius, L Müller
Krankenpflege (Frankfurt Am Main, Germany)|June 1, 1974
[Anesthesia and intensive care. VII. Cardiopulmonary resuscitation without equipment]T Valerius, B Tiemann
Krankenpflege (Frankfurt Am Main, Germany)|September 1, 1974
[Anesthesia and intensive care. IX. Teaching aids and teaching methods in resuscitation]T Valerius, B Tiemann
Critical Reviews in Oncology/Hematology|March 20, 2001
Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapyH H van Ojik, T Valerius
Pageof 7